DE145434T1 - DIHYDROPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. - Google Patents
DIHYDROPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF.Info
- Publication number
- DE145434T1 DE145434T1 DE198484308386T DE84308386T DE145434T1 DE 145434 T1 DE145434 T1 DE 145434T1 DE 198484308386 T DE198484308386 T DE 198484308386T DE 84308386 T DE84308386 T DE 84308386T DE 145434 T1 DE145434 T1 DE 145434T1
- Authority
- DE
- Germany
- Prior art keywords
- group
- optionally
- formula
- general formula
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
- C07C43/1787—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings and having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/283—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by hydrogenation of unsaturated carbon-to-carbon bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/293—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/307—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
- C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/46—Preparation of carboxylic acid esters from ketenes or polyketenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Claims (28)
worin R und R je eine niedrige Alkylgruppe;1 4
wherein R and R each represent a lower alkyl group;
-N-R , worin R eine Niedrigalkylgruppe ist, aufweist; und R eine Phenylgruppe ist, die gegebenenfalls eine Hydroxylgruppe als Substituent aufweist.7 τ
-NR, where R is a lower alkyl group; and R is a phenyl group which may optionally have a hydroxyl group as a substituent.
aufweist.-N N- in
having.
15characterized in that R is a pyridyl group, a thienyl group, a furyl group or a tetrazolyl group which optionally has a lower alkyl group as a substituent.
15th
251,4 ~ dihydro-2,6-dimethyl-4- (3-nitrophenyl) pyridine-3,5-dicarboxylate.
25th
R -5
R -
C-R1 2
CR
worin R , R und R die obengenannten Bedeutungenbesitzen, worauf die so hergestellte Verbindung der allgemeinen Formel (6) mit einer Verbindung der allgemeinen Formel (7),23 5
wherein R, R and R have the abovementioned meanings, whereupon the compound of the general formula (6) thus prepared with a compound of the general formula (7),
worin R und R die obengenannten Bedeutungen besitzen, zu dem gewünschten Dihydropyridin-Derivat der allgemeinen Formel (1) umgesetzt wird.1 4
wherein R and R have the abovementioned meanings, is converted to the desired dihydropyridine derivative of the general formula (1).
worin E , R , R und R die obengenannten Bedeutungen12 3 4
wherein E, R, R and R have the abovementioned meanings
-N-R , worin R eine Niedrigalkylgruppe ist, oder eine Gruppe der Formel -N N- ist) bedeutet, dadurch gekennzeichnet, daß eine Verbindung der allgemeinen Formel (31)7 7
-NR, in which R is a lower alkyl group, or a group of the formula -N N-), characterized in that a compound of the general formula (31)
10(31) Il Il
10
worin R die obengenannte Bedeutung besitzt, zu dem gewünschten Dihydropyridin-Derivat der allgemeinen Formel (1a) umgesetzt wird.14th
wherein R has the abovementioned meaning, is converted to the desired dihydropyridine derivative of the general formula (1a).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58228880A JPS60120861A (en) | 1983-12-02 | 1983-12-02 | Dihydropyridine derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
DE145434T1 true DE145434T1 (en) | 1986-04-10 |
Family
ID=16883307
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE198484308386T Pending DE145434T1 (en) | 1983-12-02 | 1984-12-03 | DIHYDROPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. |
DE8484308386T Expired - Lifetime DE3482823D1 (en) | 1983-12-02 | 1984-12-03 | DIHYDROPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8484308386T Expired - Lifetime DE3482823D1 (en) | 1983-12-02 | 1984-12-03 | DIHYDROPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. |
Country Status (8)
Country | Link |
---|---|
US (1) | US5034395A (en) |
EP (1) | EP0145434B1 (en) |
JP (1) | JPS60120861A (en) |
KR (1) | KR880000263B1 (en) |
DE (2) | DE145434T1 (en) |
DK (1) | DK174703B1 (en) |
ES (3) | ES8604516A1 (en) |
MX (1) | MX9202910A (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5137889A (en) * | 1983-12-02 | 1992-08-11 | Otsuka Pharmaceutical Co., Ltd. | Dihydropyridine derivatives and process for preparing the same |
ATE52030T1 (en) * | 1984-01-13 | 1990-05-15 | Yamanouchi Pharma Co Ltd | MEDICATIONS FOR THE TREATMENT AND PREVENTION OF LIVER INJURIES. |
US4672068A (en) * | 1984-05-04 | 1987-06-09 | Fujirebio Kabushiki Kaisha | Antihypertensive 1,4-dihydropyridines having a conjugated ester |
JPS60233058A (en) * | 1984-05-04 | 1985-11-19 | Fujirebio Inc | 1,4-dihydropyridine derivative |
JPS6143165A (en) * | 1984-08-07 | 1986-03-01 | Otsuka Pharmaceut Co Ltd | Preparation of dihydropyridine derivative |
JPH0676405B2 (en) * | 1986-06-13 | 1994-09-28 | 日清製粉株式会社 | 1,4-Dihydropyridine derivative and pharmaceutical composition containing the same |
IL77843A (en) * | 1985-02-11 | 1989-07-31 | Syntex Inc | Dihydropyridine derivatives,process and novel intermediates for their preparation and pharmaceutical compositions containing them |
IT1201454B (en) * | 1985-08-19 | 1989-02-02 | Boehringer Biochemia Srl | 1,4-dihydropyridine-2-SUBSTITUTED |
DE3709796C2 (en) * | 1986-03-27 | 1996-05-23 | Byk Gulden Lomberg Chem Fab | Process for the preparation of diarylpiperidyl-1,4-dihydropyridine dicarboxylic acid derivatives |
US4814455A (en) * | 1986-04-16 | 1989-03-21 | Bristol-Myers Company | Dihydro-3,5-dicarboxylates |
DE3617976A1 (en) * | 1986-05-28 | 1988-01-14 | Alter Sa | 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN ANTITHROMBOTIC MEDICATIONS |
US4761420A (en) * | 1986-06-13 | 1988-08-02 | Laboratoires Syntex S.A. | Antihypertensive dihydropyridine derivatives |
JPS63112560A (en) * | 1986-10-29 | 1988-05-17 | Green Cross Corp:The | Dihydropyridine derivative |
GB8709447D0 (en) * | 1987-04-21 | 1987-05-28 | Pfizer Ltd | Dihydropyridines |
MY104933A (en) * | 1987-09-30 | 1994-07-30 | Pfizer Ltd | Platelet activating factor antagonists |
JPH0725750B2 (en) * | 1987-12-18 | 1995-03-22 | 富士レビオ株式会社 | 1,4-dihydropyridine derivative |
JPS6425758A (en) * | 1988-07-08 | 1989-01-27 | Fujirebio Kk | 1,4-dihydropyridine derivative |
JPH0768241B2 (en) * | 1989-06-17 | 1995-07-26 | 富士レビオ株式会社 | Optically active 1,4-dihydropyridine derivative |
US5286869A (en) * | 1988-12-15 | 1994-02-15 | Fujirebio Kabushiki Kaisha | 1,4-dihydropyridine derivatives |
US5445830A (en) * | 1989-07-25 | 1995-08-29 | Otsuka Pharmaceutical Co., Ltd. | Highly absorbable pharmaceutical composition |
US5288866A (en) * | 1991-12-20 | 1994-02-22 | American Cyanamid Company | 5,6-disubstituted-3-pyridylmethyl ammonium halide compounds useful for the preparation of 5- (substituted methyl)-2,3-pyridinedicarboxylic acids |
US5321012A (en) * | 1993-01-28 | 1994-06-14 | Virginia Commonwealth University Medical College | Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance |
USRE39300E1 (en) | 1993-01-28 | 2006-09-19 | Virginia Commonwealth University Medical College Of Virginia | Inhibiting the development of tolerance to and/or dependence on an addictive substance |
US5698518A (en) * | 1994-03-30 | 1997-12-16 | Oklahoma Medical Research Foundation | Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists |
AU2788397A (en) * | 1996-05-27 | 1998-01-05 | Otsuka Pharmaceutical Co., Ltd. | Ophthalmovascular blood flow ameliorants and optic papilla protectives |
US6096759A (en) * | 1997-09-19 | 2000-08-01 | Georgetown University | Method for treating essential hypertension |
US6541479B1 (en) * | 1997-12-02 | 2003-04-01 | Massachusetts College Of Pharmacy | Calcium channel blockers |
US6306853B1 (en) | 1998-02-10 | 2001-10-23 | Nikken Chemicals Co., Ltd. | 1,4-Dihydropyridine derivatives |
IL152021A0 (en) * | 2000-04-11 | 2003-04-10 | Sankyo Co | Pharmaceutical compositions containing pyridine derivatives |
FR2874318B1 (en) * | 2004-08-19 | 2006-11-24 | Oreal | USE IN COSMETICS OF AMPHOTERIC POLYMERIC COMPOUNDS WITH CATIONIC (S) POLYMERIC (S) STRING (S) |
TW200806648A (en) * | 2005-11-29 | 2008-02-01 | Sankyo Co | Acid addition salts of dihydropyridine derivatives |
TW200736245A (en) * | 2005-11-29 | 2007-10-01 | Sankyo Co | Acid addition salts of optically active dihydropyridine derivatives |
WO2022087456A1 (en) * | 2020-10-23 | 2022-04-28 | Icahn School Of Medicine At Mount Sinai | New compounds for the treatment of alzheimer's disease |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1291258A (en) * | 1969-02-21 | 1972-10-04 | Nexus Ltd | Shelving structure |
DE2117572C3 (en) * | 1971-04-10 | 1980-03-20 | Bayer Ag, 5090 Leverkusen | Asymmetrical 1,4-dihydropyridine ^ -dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals |
DE2218644C3 (en) * | 1972-04-18 | 1982-08-19 | Bayer Ag, 5090 Leverkusen | Basic esters of 1,4-dihydropyridines, processes for their preparation and their use as pharmaceuticals |
US3985758A (en) * | 1973-02-20 | 1976-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives |
DE2508181A1 (en) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-DIHYDROPYRIDINCARBONIC ACID ARAL KYLESTER, METHOD FOR MANUFACTURING AND USING THEY AS A MEDICINAL PRODUCT |
FR2405937A1 (en) * | 1977-10-14 | 1979-05-11 | Labaz | NEW DERIVATIVES OF DIHYDROPYRIDINE, THEIR PROCESS OF PREPARATION AND THEIR APPLICATION |
US4307103A (en) * | 1978-09-08 | 1981-12-22 | Fujisawa Pharmaceutical Co., Ltd. | Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same |
DE2844595A1 (en) * | 1978-10-13 | 1980-04-30 | Bayer Ag | 2-Acylamino:alkyl-di:hydro-pyridine derivs. - useful as cardiovascular agents acting as coronary dilators, hypotensives, antiarrhythmics, vascular spasmolytics and hypolipaemics |
DE2921429A1 (en) * | 1979-05-26 | 1980-11-27 | Bayer Ag | 3-Carboxy-1,4-di:hydro-pyridine derivs. prodn. - by hydrolysing substd. ester, useful as cardiovascular agents and intermediates |
DE2935451A1 (en) * | 1979-09-01 | 1981-03-19 | Bayer Ag, 5090 Leverkusen | OPTICALLY ACTIVE 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT |
DE3023821A1 (en) * | 1980-06-25 | 1982-01-21 | Bayer Ag, 5090 Leverkusen | 4,4-DISUBSTITUTED 1,4-DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS |
DE3042769A1 (en) * | 1980-11-13 | 1982-06-09 | Bayer Ag, 5090 Leverkusen | C-3 LINKED 1,4-DIHYDROPYRIDINE, THEIR USE IN MEDICINAL PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF |
CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
JPS57175164A (en) * | 1981-04-18 | 1982-10-28 | Banyu Pharmaceut Co Ltd | 1,4-dihydropyridine derivative and its preparation |
JPS57175165A (en) * | 1981-04-21 | 1982-10-28 | Tokyo Tanabe Co Ltd | Novel 1,4-dihydropyridine-3,5-dicarboxylic diester derivative and its salt |
JPS57175166A (en) * | 1981-04-23 | 1982-10-28 | Banyu Pharmaceut Co Ltd | Carbamoyloxyalkyl-1,4-dihydropyridine derivative and its preparation |
NZ201395A (en) * | 1981-07-30 | 1987-02-20 | Bayer Ag | Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines |
DE3208628A1 (en) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | NEW COMPOUNDS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS |
WO1983003249A1 (en) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | 1,4-dihydropyridine-3,5-dicarboxylate derivatives |
EP0094159B1 (en) * | 1982-05-10 | 1990-03-14 | Takeda Chemical Industries, Ltd. | Dihydropyridine derivatives, their production and use |
US4656181A (en) * | 1982-11-24 | 1987-04-07 | Cermol S.A. | Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same |
AU561213B2 (en) * | 1983-06-02 | 1987-04-30 | Teijin Limited | 1, 4-dihydropyridine derivative |
US4672068A (en) * | 1984-05-04 | 1987-06-09 | Fujirebio Kabushiki Kaisha | Antihypertensive 1,4-dihydropyridines having a conjugated ester |
JPS6143165A (en) * | 1984-08-07 | 1986-03-01 | Otsuka Pharmaceut Co Ltd | Preparation of dihydropyridine derivative |
-
1983
- 1983-12-02 JP JP58228880A patent/JPS60120861A/en active Granted
-
1984
- 1984-11-29 DK DK198405664A patent/DK174703B1/en not_active IP Right Cessation
- 1984-11-30 ES ES538152A patent/ES8604516A1/en not_active Expired
- 1984-12-01 KR KR1019840007586A patent/KR880000263B1/en not_active IP Right Cessation
- 1984-12-03 DE DE198484308386T patent/DE145434T1/en active Pending
- 1984-12-03 DE DE8484308386T patent/DE3482823D1/en not_active Expired - Lifetime
- 1984-12-03 EP EP84308386A patent/EP0145434B1/en not_active Expired - Lifetime
-
1985
- 1985-11-07 ES ES548671A patent/ES8701726A1/en not_active Expired
- 1985-11-07 ES ES548672A patent/ES8701727A1/en not_active Expired
-
1987
- 1987-02-24 US US07/018,836 patent/US5034395A/en not_active Expired - Lifetime
-
1992
- 1992-06-16 MX MX9202910A patent/MX9202910A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES548671A0 (en) | 1986-12-01 |
JPS60120861A (en) | 1985-06-28 |
US5034395A (en) | 1991-07-23 |
ES8701727A1 (en) | 1986-12-01 |
EP0145434B1 (en) | 1990-07-25 |
ES8604516A1 (en) | 1986-02-01 |
MX9202910A (en) | 1992-06-30 |
EP0145434A2 (en) | 1985-06-19 |
DK174703B1 (en) | 2003-09-29 |
ES548672A0 (en) | 1986-12-01 |
ES8701726A1 (en) | 1986-12-01 |
KR880000263B1 (en) | 1988-03-15 |
DK566484D0 (en) | 1984-11-29 |
JPH0129187B2 (en) | 1989-06-08 |
KR850004463A (en) | 1985-07-15 |
ES538152A0 (en) | 1986-02-01 |
DK566484A (en) | 1985-07-05 |
EP0145434A3 (en) | 1987-06-16 |
DE3482823D1 (en) | 1990-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE145434T1 (en) | DIHYDROPYRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF. | |
DE1670824C3 (en) | 1,4-Dihydropyridine-33-dicarboxylic acid alkyl ester | |
DE2117571C3 (en) | Asymmetrical 1,4-dihydropyridine-33-dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals | |
DE2005116C3 (en) | Symmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid esters | |
DE2117572C3 (en) | Asymmetrical 1,4-dihydropyridine ^ -dicarboxylic acid esters, process for their preparation and their use as pharmaceuticals | |
DE2658183A1 (en) | 2-POSITION SUBSTITUTED 1,4-DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS A MEDICINAL PRODUCT | |
DE2013431C3 (en) | 4-Azidophenyl-1,4-dihydropyridine-3,5-dicarboxylic acid ester | |
EP0110073A1 (en) | Process for the preparation of tetrahydropyridines | |
DE2210633A1 (en) | NEW BRIDGE HEAD HETEROCYCLES, METHODS OF MANUFACTURING AND USING THEM AS A DRUG | |
DE2407115A1 (en) | NEW 1,4-DIHYDROPYRIDE DERIVATIVES | |
EP0048218A1 (en) | N-oxide of N-oxacyclyl-alkyl piperidines, process for their preparation, pharmaceutical compositions containing these compounds as well as their therapeutical use | |
DE1963186A1 (en) | New sulfur-containing 1,4-dihydropyridine derivatives | |
DE2228377A1 (en) | DIHYDROPYRIDINE CARBONIC ACID AMIDES, THE METHOD FOR THEIR MANUFACTURING AND THEIR USE AS A MEDICINAL PRODUCT | |
EP0010130B1 (en) | Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation | |
DE1620748C3 (en) | 2-n-Hexyl-2- (hydroxymethyl) -1,3propanediol nicotinates and process for their preparation | |
DE3109794A1 (en) | "HIGH PRESSURE REDUCING AMINES" | |
DD234424A5 (en) | METHOD FOR THE PRODUCTION OF DIHYDROPYRIDINLACTONES | |
DE2506987A1 (en) | N-SUBSTITUTED 1,4-DIHYDROPYRIDINE | |
DE2549568A1 (en) | 2,6-DIMETHYL-3-METHOXYCARBONYL-4- (2'-NITROPHENYL) -1,4-DIHYDROPYRIDINE-5-CARBONIC ACID ISOBUTYLESTER, SEVERAL METHODS OF ITS MANUFACTURING AND ITS USE AS CORONIC THERAPY | |
DE2650013B2 (en) | 1.4-Dlhydro-2.6-dimethyl-4- (3-nitrophenyl) -3.5-pyridinedicarboxylic acid isopropyK2-propoxy-ethyl) ester, process for its preparation and pharmaceuticals containing it | |
DE3414801A1 (en) | 4- (NITROPHENYL) TETRAHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT | |
DE1963185A1 (en) | 4-(nitrophenyl)-1,4-dihydropyridine derivs | |
DE1695855A1 (en) | New blood sugar lowering sulfonamides | |
DE3447170A1 (en) | MIXTURE OF DIFFERENT DIHYDROPYRIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS | |
DE2310747A1 (en) | PROCESS FOR THE MANUFACTURING OF NEW AMINO-3,4-DIHYDROPYRIDINES AND THEIR USE AS A MEDICINAL PRODUCT |